Resources

1 Resources for

pharmaceutical

Subscribe to this listing via:
RSS
Email

Show All Related Tags Did you mean pharmaceutical company (1,505 results), Millennium Pharmaceuticals Inc. (158 results), alnylam pharmaceuticals inc. (26 results), Barr Pharmaceuticals Inc. (19 results), Amylin Pharmaceuticals Inc. (17 results)more...

BNET Industries

Pharmaceutical Product Development Inc.: Pharmaceutical Product Development is a global contract research organization providing drug discovery and development services. In the Development segment, Co. provides a range of development...; Pharmaceutical Product Development Inc. company page on BNET »

BNET Resources

Pfizer (PFE), Bristol Myers Squibb (BMY): Julie catches up with participants of the big pharma-sponsored New York AIDS Walk.; Tags: Bristol-Myers Squibb Co., Pfizer Inc., AIDS, Pfizer, Bristol-Myers Squibb, pharmaceutical, cure, walk, fundraising, virus, HIV, lesbian, gay, analysts, web video, cbs, cbs news, cbs.com, howard lindzon, closing bell, julie alexandria, wallstrip, wallstreet, stocks, stock market, stock exchange, money, finance, investing, invest, nasdaq, nyse, cash, business, warren, buffet, berkshire hathaway, day trade, trends, cnbc, trading, market, jim cramer, britney; Videos 2008-05-21

Additional Resources

The benefits of being a guinea pig: you're always reading about the results of clinical trials, but can you sign up for one?: * Participating in a trial can provide you with the newest treatments and drugs for everything from allergies to cancer; in some cases, you get paid too. "These studies gather data on the safety or efficacy of medical treatments or drugs before they're released to the public," says Annice Bergeris,...; Articles 2008-09-01
Nutrition Q&A: Q I've noticed that wild yam extract is an ingredient in some testosterone-booster supplements. Will eating wild yams help to boost testosterone? A Wild yams are included in some testosterone boosters because they contain the active ingredient known as diosgenin. Pharmaceutical companies once used wild yams to make...; Articles 2008-09-01
Orexo/Prostrakan Extend Licensing Pact For Rapinyl: Orexo AB (OMX: ORX), the Swedish pharmaceutical company, and ProStrakan Group plc, the Scottish-based international specialty pharmaceutical company, have extended their existing European licensing agreement for Rapinyl Abstral, for breakthrough cancer pain, to include North America. This change of partner in North America follows the decision made by Endo Pharmaceuticals...; Articles 2008-09-01
BioAlliance Pharma SA publishes its consolidated half-year accounts to June 30, 2008: BioAlliance Pharma publishes its consolidated half-year accounts to June 30, 2008: increased revenue and reinforced growth vianew licensing agreements Paris, August 28, 2008 - BioAlliance Pharma SA (Euronext Paris, ISIN code:FR0010095596-BIO), the specialty pharmaceutical company focused on thetreatment of opportunistic infections in cancer and HIV, has published itsconsolidated accounts to...; Articles 2008-08-28

According to Cutting Edge Information Research, Patient Recruitment Costs Having Greater Impact on Clinical Development: The difficulty of recruitingsuitable patients for clinical trials has been a greater factor in risingtrial costs, according survey data collected from pharmaceutical companies.A new study by pharmaceutical business intelligence leader Cutting EdgeInformation, "Streamlining Clinical Trials," finds that on a cost-impactscale of 1-5, patient recruitment received a mark of 4.1, a...; Articles 2008-08-28
Transdel Pharmaceuticals to Present at 2008 Southern California Investor Conference: Transdel Pharmaceuticals, Inc. (OTCBB: TDLP)today announced that President and Chief Executive Officer Dr. Juliet Singhwill present a company overview at the California Stock Report's 2008Southern California Investor Conference at 9:30 a.m. Pacific Time onWednesday, September 3, 2008 at The Island Hotel in Newport Beach, Calif. Interested parties may listen to...; Articles 2008-08-27
IPC Saves $1 Million Developing Drug-Tracking System With iWay Software: iWay Software, an Information Builders companyand an innovator of enterpriseintegration solutions, today announced that IPC, the nation's largestgroup purchasing organization for independent pharmacies, used InformationBuilders iWay Software to meet drug tracking requirements in completecompliance with U.S. Food and Drug Administration FDA standards. IPCcompleted the project for a fraction...; Articles 2008-08-27
Hough Associates, Inc. Announces The Launch Of Their New, Resource-Rich Website: NEW CASTLE, Del. -- Hough Associates, Inc., one of the area's leading engineering companies, announces the launch of their new, resource-rich website. Resources include various articles on how to choose the right engineering company, questions to ask before the work starts, and links to industry-related websites. While they...; Articles 2008-08-27
DOR BioPharma Announces Named Patient Access Program for orBec(R) in Thailand and Other ASEAN Countries in Collaboration With Pacific Healthcare: DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the"Company"), a late-stage biopharmaceutical company developing products totreat the life-threatening side effects of cancer treatments and seriousgastrointestinal diseases, and vaccines against certain bioterrorismagents, announced today that it has entered into a collaboration withPacific Healthcare Thailand Co., Ltd. Pacific, a specialty pharmaceuticalcompany based in...; Articles 2008-08-27
IMS to Present at Thomas Weisel Partners Conference on September 4 at 9:10 a.m. ET: NORWALK, Conn. -- IMS Health (NYSE: RX), the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that David Carlucci, chairman and chief executive officer, will speak to investors and analysts attending the Thomas Weisel Partners Healthcare Conference, to be held at The Four Seasons...; Articles 2008-08-27
4 More Deaths Reported Among Byetta Patients: The makers of the type 2 diabetes drug Byetta reported Tuesday the deaths of four more people who'd been taking the medication. The announcement by Eli Lilly and Amylin Pharmaceuticals Inc. came a week after the U.S. Food and Drug Administration said that two Byetta users had died of acute...; Articles 2008-08-27
TB Alliance Appoints First Chief Administrative Officer: Healthcare Executive Colleen Pero to Guide Growth of World's Leading TB Drug Development Organization NEW YORK -- The Global Alliance for TB Drug Development TB Alliance, a not-for-profit product development partnership accelerating the discovery and development of new drugs to fight tuberculosis TB, today announced the appointment of...; Articles 2008-08-27
BioAlliance Pharma SA appoints Pierre MORGON Chief Operating Officer: BioAlliance Pharma SA (Euronext Paris - CodeIsin: FR0010095596 -BIO), the specialty pharmaceutical companyfocused on the treatment of opportunistic infections in cancer andHIV, today announced that it has strengthened its Management Boardwith the appointment of Pierre MORGON as Chief Operating OfficerCOO. Pierre A. MORGON, 45, PharmD, MS Law, MBA spent 23...; Articles 2008-08-27
AMAG Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences: CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and Chief Executive Officer, will present an overview of the Company at two upcoming investor conferences. Dr. Pereira will present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008 at 8:35...; Articles 2008-08-27
Bio-Imaging Technologies to Present at Kaufman Bros., L.P. 11th Annual Investor Conference on September 5, 2008 at 9 AM Eastern Daylight Time: Conference Located at The W Hotel, New York City, September 3-5, 2008 NEWTOWN, Pa. -- Bio-Imaging Technologies, Inc. ("Bio-Imaging") (NASDAQ: BITI) today announced that its President and Chief Executive Officer, Mark L. Weinstein, is scheduled to present at the Kaufman Bros., L.P. 11th Annual Investor Conference 9:00 am...; Articles 2008-08-27
Advanced ID Corp. Rated 'Speculative Buy,' Target Price $0.35 by Beacon Equity Research: DALLAS -- Advanced ID Corp. (OTCBB: AIDO) has been rated Speculative Buy with a price target of $0.35 by Beacon Analyst, Victor Sula, Ph.D. The full report is available at http://www.beaconequity.com/adpages/AIDO Anyone interested in receiving alerts regarding AIDO research should e-mail members@beaconequity.com with "AIDO" in the...; Articles 2008-08-27
Santarus to Present at Two September Investment Conferences: SAN DIEGO -- Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that Gerald T. Proehl, president and chief executive officer, will make presentations at the following investment community conferences during the month of September: * Thomas Weisel Partners Healthcare Conference 2008 being held at the Four Seasons...; Articles 2008-08-27
Drug lawsuit will proceed in 'inconvenient' St. Louis: In a blow to pharmaceutical companies, the Missouri Supreme Court on Tuesday ruled that personal injury cases against makers of hormone-therapy drugs can proceed in St. Louis Circuit Court. The court decided 6-0 to uphold St. Louis Circuit Judge Thomas Grady, who denied the drug companies' motion...; Articles 2008-08-27
Brentwood-based KV directors, officers will repay $3 million: Brentwood-based KV Pharmaceutical is entitled to more than $3 million from officers and directors who backdated stock options, according to a settlement approved Tuesday by U.S. District Judge Henry E. Autrey. The lawsuit, filed by two plaintiffs on behalf of KV, alleged members of the company's board...; Articles 2008-08-27

<< Previous
page 1 of 1
Next >>

Resources

pharmaceutical

BNET Industries

BNET Resources

Additional Resources

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors